SG Americas Securities’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$290K Sell
37,790
-11,307
-23% -$77.4K ﹤0.01% 2475
2025
Q4
$97K Buy
49,097
+18,791
+62% +$42.6K ﹤0.01% 3248
2025
Q3
$75K Buy
+30,306
New +$78K ﹤0.01% 3136
2025
Q2
Sell
-42,188
Closed -$127K 3236
2025
Q1
$127K Sell
42,188
-18,152
-30% -$55K ﹤0.01% 2871
2024
Q4
$154K Buy
60,340
+565
+0.9% +$2.35K ﹤0.01% 2389
2024
Q3
$222K Buy
+59,775
New +$277K ﹤0.01% 2408
2024
Q1
Sell
-49,005
Closed -$246K 3184
2023
Q4
$246K Buy
49,005
+15,308
+45% +$48K ﹤0.01% 1978
2023
Q3
$57K Buy
+33,697
New +$67.7K ﹤0.01% 2909
2023
Q2
Sell
-51,013
Closed -$93K 2682
2023
Q1
$93K Buy
51,013
+33,613
+193% +$105K ﹤0.01% 2937
2022
Q4
$88K Sell
17,400
-80,262
-82% -$441K ﹤0.01% 2754
2022
Q3
$485K Buy
97,662
+256
+0.3% +$1.17K 0.01% 1578
2022
Q2
$362K Buy
97,406
+47,410
+95% +$190K ﹤0.01% 2236
2022
Q1
$280K Buy
49,996
+23,617
+90% +$145K ﹤0.01% 2228
2021
Q4
$160K Sell
26,379
-51,006
-66% -$383K ﹤0.01% 2782
2021
Q3
$754K Buy
77,385
+45,125
+140% +$497K ﹤0.01% 2149
2021
Q2
$461K Buy
32,260
+19,340
+150% +$319K ﹤0.01% 1976
2021
Q1
$307K Buy
12,920
+2,789
+28% +$72.3K ﹤0.01% 2360
2020
Q4
$135K Buy
+10,131
New +$97.5K ﹤0.01% 2878
2020
Q3
Sell
-15,635
Closed -$192K 3050
2020
Q2
$192K Buy
+15,635
New +$88.3K ﹤0.01% 2891
2019
Q1
Sell
-42,111
Closed -$49K 3471
2018
Q4
$49K Buy
+42,111
New +$96.3K ﹤0.01% 2827
2018
Q2
Sell
-21,812
Closed -$85K 3425
2018
Q1
$85K Buy
+21,812
New +$95.6K ﹤0.01% 3003
2017
Q4
Sell
-49,356
Closed -$270K 3396
2017
Q3
$270K Buy
49,356
+35,424
+254% +$218K ﹤0.01% 2340
2017
Q2
$106K Sell
13,932
-13,104
-48% -$56.6K ﹤0.01% 2877
2017
Q1
$96K Sell
27,036
-1,639
-6% -$8.1K ﹤0.01% 3005
2016
Q4
$164K Buy
+28,675
New +$191K ﹤0.01% 2509

Other funds holding IBRX